Ignite Creation Date:
2025-12-24 @ 10:55 PM
Ignite Modification Date:
2026-01-01 @ 3:42 AM
Study NCT ID:
NCT05245669
Status:
COMPLETED
Last Update Posted:
2025-12-23
First Post:
2022-01-11
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Study to Compare the Pharmacokinetics, Pharmacodynamics, Safety, Tolerability, and Immunogenicity of Biosimilar Denosumab With Prolia® in Healthy Adult Male Volunteers
Sponsor:
Enzene Biosciences Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-01-10
Start Date Type:
ACTUAL
Primary Completion Date:
2024-05-22
Primary Completion Date Type:
ACTUAL
Completion Date:
2024-05-22
Completion Date Type:
ACTUAL
First Submit Date:
2022-01-11
First Submit QC Date:
None
Study First Post Date:
2022-02-18
Study First Post Date Type:
ACTUAL
Results First Submit Date:
2025-11-30
Results First Submit QC Date:
None
Results First Post Date:
2025-12-23
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-20
Last Update Post Date:
2025-12-23
Last Update Post Date Type:
ESTIMATED